A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer
Clinical trial NCT00116753 · COMPLETED
Trial details
- NCT number
- NCT00116753
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2006-11-01
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.